Literature DB >> 29079187

Overexpression of eEF1A1 regulates G1-phase progression to promote HCC proliferation through the STAT1-cyclin D1 pathway.

Jian Huang1, Chuqian Zheng1, Jun Shao1, Leifeng Chen1, Xiuxia Liu2, Jianghua Shao3.   

Abstract

Hepatocellular carcinoma (HCC) is a common cancer worldwide with an aggressive and highly proliferative activity. Studies had confirmed that HCC cell proliferation is associated with the cell cycle's G1 phase, but the detailed molecular mechanism has not been thoroughly elucidated to date. Eukaryotic translation elongation factor 1A1 (eEF1A1) is an evolutionarily conserved elongation factor protein and is involved in tumor cell proliferation. However, which phase of the cell cycle is regulated by eEF1A1 to influence cell proliferation in HCC and its detailed molecular mechanism remain unclear. In this study, we observed that eEF1A1 influences HCC cell proliferation by regulating the cell cycle's G1 phase. In addition, eEF1A1 influences G1 phase by regulating cyclin D1 expression, promoting HCC cell proliferation both in vitro and in vivo. Moreover, our results indicated that eEF1A1 regulates cyclin D1 expression through STAT1 signaling. STAT1 increases the transcriptional activity of cyclin D1 by binding to the cyclin D1 promoter. Taken together, these findings enabled us to identify a novel mechanism by which eEF1A1 regulates the cell cycle's G1 phase to promote tumor proliferation by regulating cyclin D1 expression through STAT1 signaling in HCC.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell cycle; Cyclin D1; Hepatocellular carcinoma; Proliferation; eEF1A1

Mesh:

Substances:

Year:  2017        PMID: 29079187     DOI: 10.1016/j.bbrc.2017.10.116

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  DcR3 promotes proliferation and invasion of pancreatic cancer via a DcR3/STAT1/IRF1 feedback loop.

Authors:  Yijun Wei; Xingyu Chen; Jian Yang; Jun Yao; Ni Yin; Zixiang Zhang; Dechun Li; Dongming Zhu; Jian Zhou
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

2.  Dimethylation of eEF1A at Lysine 55 Plays a Key Role in the Regulation of eEF1A2 on Malignant Cell Functions of Acute Myeloid Leukemia.

Authors:  Shan Xiao; Yanping Wang; Yuwen Ma; Jue Liu; Can'e Tang; Aiping Deng; Chunxiang Fang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

3.  Expression of EEF1A1 Is Associated with Prognosis of Patients with Colon Adenocarcinoma.

Authors:  Eun Kyo Joung; Jiyoung Kim; Nara Yoon; Lee-So Maeng; Ji Hoon Kim; Sungsoo Park; Keunsoo Kang; Jeong Seon Kim; Young-Ho Ahn; Yoon Ho Ko; Jae Ho Byun; Ji Hyung Hong
Journal:  J Clin Med       Date:  2019-11-07       Impact factor: 4.241

4.  Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.

Authors:  Nan Mei; Ni Zhao; Tao Tian; Min Jiao; Chunli Li
Journal:  Pharmacol Res Perspect       Date:  2021-02

5.  Expression and Clinical Value of Eukaryotic Translation Elongation Factor 1A1 (EEF1A1) in Diffuse Large B Cell Lymphoma.

Authors:  Tiejun Gong; Yuerong Shuang
Journal:  Int J Gen Med       Date:  2021-10-27

6.  Glyphosate Interaction with eEF1α1 Indicates Altered Protein Synthesis: Evidence for Reduced Spermatogenesis and Cytostatic Effect.

Authors:  Bruno Sopko; Gracian Tejral; Guissepe Bitti; Marianna Abate; Martina Medvedikova; Marian Hajduch; Jan Chloupek; Jolana Fajmonova; Misa Skoric; Evzen Amler; Tomas Erban
Journal:  ACS Omega       Date:  2021-06-02

7.  Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress.

Authors:  Cheng-Yu Lin; Alexandra Beattie; Behzad Baradaran; Eloise Dray; Pascal H G Duijf
Journal:  Sci Rep       Date:  2018-09-17       Impact factor: 4.379

8.  TSG101 promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by regulating the PEG10.

Authors:  Zhiyi Liu; Zilu Tian; Kuan Cao; Bin Zhang; Quan Wen; Xinyu Zhou; Weibin Yang; Tao Wang; Hengliang Shi; Renhao Wang
Journal:  J Cell Mol Med       Date:  2018-11-18       Impact factor: 5.310

9.  Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway.

Authors:  Ruijie Sun; Ruiren Zhai; Changlin Ma; Wei Miao
Journal:  Cancer Med       Date:  2019-12-12       Impact factor: 4.452

10.  LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1.

Authors:  Weidan Ji; Zhangxiao Peng; Bin Sun; Lei Chen; Qin Zhang; Minggao Guo; Changqing Su
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.